ミズーリ州における卵巣がんの臨床試験
ミズーリ州内の拠点で、卵巣がんに関する41件の研究が参加者を募集しています。
ミズーリ州内の都市
公式研究テキスト（英語）
The Vanguard Study: Testing a New Way to Screen for Cancer
- Saint Luke's Hospital of Kansas City, Kansas City
- Washington University School of Medicine, St Louis
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/10/05更新 · NCT06995898Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Washington University School of Medicine in St. Louis, St Louis
被験者募集中第3相
18歳以上 · 女性 · 2026/10/05更新 · NCT06915025Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 他2件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07001748Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Saint Francis Medical Center, Cape Girardeau
- Saint Luke's Hospital, Chesterfield
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- 他13件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/05更新 · NCT05564377A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Washington University Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Washington University School of Medicine in St. Louis, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Washington University, School of Medicine, St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
- WU St Louis, St Louis
被験者募集中
18歳以上 · 女性 · 2026/09/29更新 · NCT05287451First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06799065A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Cox Medical Center South /ID# 274826, Springfield
- Mercy David C. Pratt Cancer Center /ID# 275655, St Louis
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT06890338Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Washington University, St Louis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- University of Missouri Hospital, Columbia
- HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City
- Cox Medical Center North, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Washington University School of Medicine in St. Louis, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Washington Univ. School of Medicine, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Mercy Hospital St. Louis - David C. Pratt Cancer Center, St Louis
被験者募集中第3相
18歳以上 · 女性 · 2026/09/15更新 · NCT07214779A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Washington University, St Louis
被験者募集中第2相
18歳〜99歳 · 女性 · 2026/09/15更新 · NCT07023627A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT05123482A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Washington University School of Medicine ( Site 0052), St Louis
被験者募集中第3相
18歳以上 · 女性 · 2026/09/03更新 · NCT06824467Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- Washington University School of Medicine, St Louis
- Mercy Hospital St. Louis, St Louis
被験者募集中第3相
18歳以上 · 女性 · 2026/08/26更新 · NCT05281471Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Washington University, Siteman Cancer Center, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06774963A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Mercy Hospital Springfield, Springfield
- Washington University School of Medicine, St Louis
- Missouri Baptist Medical Center, St Louis
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- 他20件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314IDOV-Immune for Advanced Solid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06910657A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Washington University School of Medicine Obstetrics and Gynecology, St Louis
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/07/28更新 · NCT06161025A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #110, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06545942Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 334, Kansas City
- 521, St Louis
被験者募集中第2相
18歳以上 · 女性 · 2026/07/16更新 · NCT06906341First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Saint Luke's Cancer Institute, Kansas City
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Saint Louis University, St Louis
被験者募集中第1/2相
18歳〜90歳 · 全性別 · 2026/07/06更新 · NCT06710756Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- 他3件
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
- Washington University School of Medicine in St. Louis, St Louis
被験者募集中第1相
18歳以上 · 女性 · 2026/05/28更新 · NCT06930755JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
- Research site, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06386146Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center North, Kansas City
- University of Kansas Cancer Center Lee's Summit, Lee's Summit
- 他1件
被験者募集中第3相
18歳以上 · 女性 · 2026/04/16更新 · NCT05659381A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0111, St Louis
被験者募集中第1相
18歳以上 · 女性 · 2026/04/07更新 · NCT04516447TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- Washington University Medical Center, St Louis
被験者募集中
25歳〜50歳 · 女性 · 2026/04/06更新 · NCT04294927CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Washington University, St Louis
被験者募集中第2相
18歳以上 · 女性 · 2025/12/23更新 · NCT06690775ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。